RECRUITING

Sevoflurane/Dexmedetomidine Vs. Isoflurane for Pediatric Emergence Delirium

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to measure the incidences of pediatric emergence delirium between the group receiving Isoflurane and the group receiving Sevoflurane plus intravenous push dexmedetomidine.

Official Title

Sevoflurane/Dexmedetomidine Vs. Isoflurane and Their Effects on Pediatric Emergence Delirium

Quick Facts

Study Start:2024-12-20
Study Completion:2026-11-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06624592

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:2 Years to 7 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Pediatric patients aged 2-7 years.
  2. * Surgeries include ENT cases (i.e., tonsillectomy/adenoidectomy), ophthalmology cases (i.e., strabismus), and urology cases.
  3. * Can be outpatient or General Care inpatient procedures.
  4. * All cases must include an IV and an endotracheal tube (ETT).
  1. * Severe developmental/cognitive delay (unable to make eye contact, nonverbal, or inability to interact with providers for PAED scale assessment requirements)
  2. * TIVA cases.
  3. * No PIV in place during the case, planned PICU admission postoperatively.
  4. * Previous history of severe emergence delirium documented by a provider (via interventions or explicitly stated).

Contacts and Locations

Study Contact

Lindsay Warner, MD
CONTACT
507-284-2511
warner.lindsay@mayo.edu
Molly Herr, MD
CONTACT
507-284-2511
herr.molly@mayo.edu

Principal Investigator

Lindsay Warner, MD
PRINCIPAL_INVESTIGATOR
Mayo Clinic

Study Locations (Sites)

Mayo Clinic in Rochester
Rochester, Minnesota, 55905
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Lindsay Warner, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-20
Study Completion Date2026-11-01

Study Record Updates

Study Start Date2024-12-20
Study Completion Date2026-11-01

Terms related to this study

Additional Relevant MeSH Terms

  • Delirium on Emergence